What's Next For TRYP Therapeutics? BIG Update (CSE:TRYP)

What's Next For TRYP Therapeutics? BIG Update (CSE:TRYP)Подробнее

Tryp Therapeutics new CEO looking to take big steps this year with a number of partnershipsПодробнее

How Tryptamine Therapeutics (ASX:TYP) is accelerating innovative psychedelic therapiesПодробнее

Tryp Therapeutics Inc InterviewПодробнее

Biotech Tryp Therapeutics hits the ASX with a bangПодробнее

New Listing: Tryp Therapeutics Inc. (CSE:TRYP)Подробнее

Introducing James Kuo and TRYP Therapeutics (CSE:TRYP) | Investing in PsychedelicsПодробнее

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF)Подробнее

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Path Notably Similar to Successful Cannabis PioneeПодробнее

Tryp Therapeutics Inc. (CSE:TRYP) Opens the Stock Market | Canadian Securities ExchangeПодробнее

Next Wave of Psychedelic Drug Development: Pain & Eating Disorders | TRYP Therapeutics $TRYPПодробнее

Tryp Therapeutics Inc. (OTCQB: TRYPF | CSE: TRYP): Virtual Investor ConferencesПодробнее

#SmallCapCentral: Tryp Therapeutics (ASX: TYP) Completes Phase 2a Fibromyalgia TrialПодробнее

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Breaks New Ground in Psilocybin SpaceПодробнее

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) on Mission to Provide Powerful Development in PsycПодробнее

Tryp Therapeutics discusses unique approach to psychedelic treatment study of binge eatingПодробнее

Breaking News - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF)Подробнее

Tryp Therapeutics Inc, Greg McKee, Chairman & CEOПодробнее

Tryp Therapeutics & Mass General Hospital Study Psilocybin for IBS PainПодробнее

Scientific Rigor and Strong Team Pave Way for Tryp Therapeutic’s Continued GrowthПодробнее